All news

Form SCHEDULE 13G BioStem Technologies, Filed by: PNC FINANCIAL SERVICES GROUP, INC.

Alpha Vantage · StreetInsider · · AI-summarised by FinFlash

The PNC Financial Services Group, Inc. has filed a Schedule 13G form with the SEC regarding BioStem Technologies, Inc. This filing indicates that PNC beneficially owns 1,941,390 shares, representing 10.40% of the company's common stock. The shares are held in a fiduciary capacity by PNC Bank, National Association and PNC Ohio Trust Company for clients.

Read original source

PNC company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.